MARKET OPPORTUNITY
OrthoFuzIon ® Bone Screws are indicated for open reduction and internal fixation (ORIF) fracture surgeries and are plated to inhibit microbial colonization and reduce implant-related infection in revision surgery due to implant infection or primary surgery in patients who are at-risk of implant infections.
The Silver Bullet opportunity.
Why infection prevention matters.
Medical device-related contaminations can have lasting consequences for both patients and healthcare providers. As healthcare systems increasingly focus on improving outcomes while reducing costs, technologies that help precent implant-related complications are becoming increasingly important.
A growing market need.
The demand for orthopedic implants continues to increase as the population ages and procedural volumes grow. At the same time, hospitals are under greater financial pressure to reduce preventable complications.
The Centers for Medicare & Medicaid Services (CMS) introduced the Bundled Payments for Care Improvement (BPCI) initiative to encourage providers to manage the total cost of care, including complications following surgery. This shift toward value-based reimbursement creates additional incentive for technologies designed to reduce implant-related complications and improve long-term patient outcomes.
A platform designed from growth.
While the initial application of the technology is the OrthoFuzIon™ Antimicrobial Bone Screw System, Silver Bullet's proprietary coating platform has the potential to expand across a broad range of implantable medical devices. This platform approach creates opportunities to address infection prevention in multiple specialties while leveraging the same underlying antimicrobial technology.
Over a decade of development.
Silver Bullet Therapeutics has invested more than fifteen years in developing and refining its proprietary antimicrobial coating technology. Through extensive research, laboratory testing, and animal studies, the company has advanced a coating process designed to deliver durable antimicrobial performance while meeting the demanding mechanical requirements of orthopedic implants.
In conversation with Silver Bullet Therapeutics
*
In conversation with Silver Bullet Therapeutics *
Silver Bullet Therapeutics joins BoneChat to discuss antimicrobial implant technology, the company’s proprietary coating platform, and the ongoing efforts to address contamination associated with medical device implants.